Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Un- audited Financial Results ....
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kronox Lab Sciences has informed the exchanges that its Board of Directors will meet on February 14, 2026 to consider and approve the Un-audited Standalone Financial Results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The filing is a standard regulatory disclosure under SEBI LODR Regulation 29. The trading window for directors, officers, and designated employees remains closed from January 1, 2026 until 48 hours after the results are declared, as is customary ahead of results announcement. No financial numbers, guidance, or special agenda items are disclosed in this intimation.
This is a routine procedural filing with no direct impact on shareholders. Investors should watch for the actual Q3 FY26 results on or after February 14, 2026, which will provide insights into the company's financial performance for the December quarter.